Clindamycin MIP
Clindamycin MIP is an antibiotic used to treat various bacterial infections by stopping bacteria from growing.
Form
tabletti, kalvopäällysteinen
Strength
600 mg
Active Ingredient
Clindamycin hydrochloride
Manufacturer
MIP Pharma GmbH
How to Use
Dosage
For adults and adolescents over 14 years, typically 0.6 to 1.8 grams of clindamycin per day, divided into four doses. For children 4 weeks to 14 years, 8 mg to 25 mg of clindamycin per kilogram of body weight per day, divided into 3-4 doses. Always follow your doctor's instructions.
Method
Swallow the tablets whole with plenty of water, preferably a full glass. Do not chew the tablets.
Important
The maximum daily dose for adults and adolescents over 14 years is 1.8 grams of clindamycin. For children, the maximum daily dose is 25 mg per kilogram of body weight.
Possible Side Effects
COMMON
- •Stomach or bowel problems like stomach pain, feeling sick (nausea), throwing up (vomiting), and diarrhea.
RARE
- •Changes in blood cell counts (like low platelets, white blood cells, or other blood cells).
- •Fever caused by the medicine.
- •Severe allergic reaction (anaphylactic shock) with swelling of the face, blood vessels, or throat, difficulty breathing, and even collapse.
- •Problems with nerves communicating with muscles (neuromuscular blockade).
- •Changes in taste and smell.
- •Dizziness, headache.
- •Severe inflammation of the large intestine (pseudomembranous colitis).
- •Inflammation of the esophagus, tongue, or mouth.
- •Slight and temporary increase in liver enzyme levels (seen in blood tests).
- •Temporary liver inflammation (hepatitis) with yellowing of the skin or eyes (jaundice) due to bile blockage.
- •Allergic skin reactions, such as a rash similar to measles, itching, and hives.
- •Swelling (e.g., angioedema, a type of swelling affecting deeper skin tissues).
- •Severe widespread skin rashes that may include blisters (e.g., Stevens-Johnson syndrome, Lyell's syndrome).
- •Itching, vaginal inflammation (discharge), and skin inflammation with flaking or blisters.
- •Joint swelling.
- •Inflammation of several joints (polyarthritis).
Important Warnings
- Do not take this medicine if you are allergic to clindamycin, lincomycin, or any other ingredient in the tablets.
- Tell your doctor if you have problems with your liver or kidneys.
- Tell your doctor if you have muscle weakness conditions like myasthenia gravis or Parkinson's disease.
- Tell your doctor if you have a history of stomach or bowel diseases, such as inflammation of the colon.
- Severe allergic reactions (swelling of the face, throat, or difficulty breathing, even shock) can happen very rarely. Get medical help right away if this occurs.
Show 7 more warnings
- Antibiotic-related bowel inflammation (colitis) can occur very rarely, even up to three weeks after stopping the medicine. Symptoms include watery diarrhea, fever, severe stomach pain, and possibly blood or mucus in stools. If you experience these symptoms, stop taking the medicine and contact your doctor immediately.
- If you take this medicine for more than three weeks, your doctor will need to do regular blood tests and check your liver and kidney function.
- Acute kidney damage can occur. Tell your doctor about all medicines you are taking and any kidney problems you have. If you have less urine, swelling in your legs, ankles, or feet from fluid buildup, shortness of breath, or feel sick, contact your doctor immediately.
- Long-term or repeated use of clindamycin can lead to new infections by bacteria or yeast that this medicine cannot treat.
- This medicine should not be used to treat sudden breathing infections if they are caused by viruses.
- Clindamycin MIP is not effective for treating meningitis (inflammation of the brain's covering).
- Do not stop taking this medicine or change your treatment without talking to your doctor first, even if you feel better. Stopping early can make the infection worse or come back.
Use in Elderly Patients
Category A
Suitable for older adults. Bear in mind the risk of pseudomembranous colitis. (updated 4.12.2023)